These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population]. Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315 [TBL] [Abstract][Full Text] [Related]
6. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600 [TBL] [Abstract][Full Text] [Related]
7. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Spencer K; Cowans NJ; Avgidou K; Nicolaides KH Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214 [TBL] [Abstract][Full Text] [Related]
8. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105 [TBL] [Abstract][Full Text] [Related]
9. First trimester predictors of adverse pregnancy outcomes. Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038 [TBL] [Abstract][Full Text] [Related]
10. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186 [TBL] [Abstract][Full Text] [Related]
11. Maternal serum screening for aneuploidy and open fetal defects. Canick JA; Saller DN Obstet Gynecol Clin North Am; 1993 Sep; 20(3):443-54. PubMed ID: 8278144 [TBL] [Abstract][Full Text] [Related]
12. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening. Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324 [TBL] [Abstract][Full Text] [Related]
13. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years. Biggio JR; Morris TC; Owen J; Stringer JS Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005 [TBL] [Abstract][Full Text] [Related]
19. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381 [TBL] [Abstract][Full Text] [Related]
20. A summary analysis of Down syndrome markers in the late first trimester. Palomaki GE; Lambert-Messerlian GM; Canick JA Adv Clin Chem; 2007; 43():177-210. PubMed ID: 17249384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]